Pregled bibliografske jedinice broj: 1187217
Vitamin D supplementation in patients with atopic dermatitis, chronic urticaria or contact dermatitis – possible improvements without risk
Vitamin D supplementation in patients with atopic dermatitis, chronic urticaria or contact dermatitis – possible improvements without risk // Folia medica, 64 (2022), 3; 467-477 doi:10.3897/folmed.64.e66166 (međunarodna recenzija, članak, znanstveni)
CROSBI ID: 1187217 Za ispravke kontaktirajte CROSBI podršku putem web obrasca
Naslov
Vitamin D supplementation in patients with atopic
dermatitis, chronic urticaria or contact
dermatitis – possible improvements without risk
Autori
Lugović Mihić, Liborija ; Mandušić, Nikolina ; Pondeljak, Nives ; Kuna, Matea ; Pozderac, Iva
Izvornik
Folia medica (0204-8043) 64
(2022), 3;
467-477
Vrsta, podvrsta i kategorija rada
Radovi u časopisima, članak, znanstveni
Ključne riječi
allergic diseases ; eczema ; vitamin D deficiency ; cholecalciferol ; skin inflammatory diseases
Sažetak
Introduction: There has been a lot of talk lately about the importance of reduced serum vitamin D levels and their supplementation for patients with inflammatory skin diseases such as atopic dermatitis (AD) as well as other allergic diseases. The serum vitamin D values are associated with a number of factors such as limited sunlight exposure (modern lifestyle, extended indoor stay, enhanced sun protection, etc.) which can affect different diseases. Aim: Evaluating serum vitamin D values in patients with inflammatory skin diseases, comparing them on the basis of other parameters (age, gender/sex, residential areas, total serum IgE), and establishing if vitamin D supplementation would affect the improvement of the clinical picture of the disease. Patients and Methods: A total of 157 patients participated in this prospective study: 51 patients with AD, 55 with chronic urticaria (CU) and 51 with contact dermatitis (CD): 38 with irritant CD (ICD) and 13 with allergic CD (ACD). In all patients, the values of serum vitamin D were determined by chemiluminescence microparticle immunoassay (CMIA) and compared by diagnosis, age, sex, living environment, values of total IgE. In patients with reduced values of vitamin D, its supplementation for 3 months was recommended, after which the second evaluation of D vitamin values and disease status were determined and compared with an untreated/unsupplemented group with normal vitamin D values. Results: Vitamin D deficiency was often observed in patients with AD, CU and CD, most frequently in the ICD group, and least frequently in the ACD group. No significant differences were found in terms of age, gender or living environment, nor did they correlate with total IgE. In the subjects supplemented with vitamin D, their levels increased significantly and, after its supplementation, improvement of the clinical condition was more common than in the untreated group ; however, the differences were not statistically significant (69.8 vs 58.1 ; p=0.428). Conclusion Although the serum vitamin D levels of the groups did not differ significantly, the supplementation of vitamin D in patients with prominent vitamin D deficiency may be useful and crucial for improving the prognosis of the disease.
Izvorni jezik
Engleski
Znanstvena područja
Biotehnologija u biomedicini (prirodno područje, biomedicina i zdravstvo, biotehničko područje)
POVEZANOST RADA
Ustanove:
Stomatološki fakultet, Zagreb,
KBC "Sestre Milosrdnice",
Klinička bolnica "Dubrava"
Citiraj ovu publikaciju:
Časopis indeksira:
- Scopus
- MEDLINE